1 Lehmann JS, Matthias MA, Vinetz JM, Fouts DE. Leptospiral pathogenomics. Pathogens. 2014;3(2):280–308.
2 Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis. 2015;e0003898.
3 Nau LH, Emirhar D, Obiegala A, Mylius M, Runge M, Jacob J, et al. Leptospirose in Deutschland: Aktuelle Erkenntnisse zu Erregerspezies, Reservoirwirten und Erkrankungen bei Mensch und Tier. Bundesgesundheitsbl. 2019;1510–21.
4 Frederick S. Southwick. Infectious Diseases: A Clinical Short Course. 4th ed. Gainesville: McGraw-Hill; 2020.
5 Gochenour WS, Smadel JE, Jackson EB, Evans LB, Yager RH. Leptospiral etiology of Fort Bragg fever. Publ Hlth Rep. 1952;67:811–3.
6 Woods K, Nic-Fhogartaigh C, Arnold C, Boutthasavong L, Phuklia W, Lim C, et al. A comparison of two molecular methods for diagnosing leptospirosis from three different sample types in patients presenting with fever in Laos. Clin Microbiol Infect. 2018;1017.e1–1017.e7.
7 Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev. 2012;(2):CD008264.
8 Charan J, Saxena D, Mulla S. Prophylaxis and Treatment of Leptospirosis. National Journal of Physiology, Pharmacy and Pharmacology. 2012;2:78–83.